BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31103821)

  • 21. miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
    Lin KH; Kumar VB; Shanmugam T; Shibu MA; Chen RJ; Kuo CH; Ho TJ; Padma VV; Yeh YL; Huang CY
    Mol Cell Biochem; 2021 Sep; 476(9):3253-3260. PubMed ID: 33886061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-384-5p protects against cardiac hypertrophy via the ALPK3 signaling pathway.
    Guo S; Yang Y; Qian W; Yao Y; Zhou G; Shen L; Zhou J
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23093. PubMed ID: 35510648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
    An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
    Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ming S; Shui-Yun W; Wei Q; Jian-Hui L; Ru-Tai H; Lei S; Mei J; Hui W; Ji-Zheng W
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29440459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
    Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-Mediated Downregulation of HMGB2 Contributes to Cellular Senescence in Microvascular Endothelial Cells.
    Jo HR; Jeong JH
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Puerarin from Pueraria lobate attenuates ischemia-induced cardiac injuries and inflammation in vitro and in vivo: The key role of miR-130a-5p/HMGB2 pathway.
    Fan C; Wang Q; Chen Y; Ye T; Fan Y
    Chem Biol Drug Des; 2023 Apr; 101(4):952-961. PubMed ID: 36601671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL; Lv JB; Gao L
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR-182-5p/IGF1 axis.
    Wang D; Lin B; Zhang W; Wang X
    Cell Biol Int; 2020 Jul; 44(7):1426-1435. PubMed ID: 32125046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
    Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
    Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ.
    He J; Jiang S; Li FL; Zhao XJ; Chu EF; Sun MN; Chen MZ; Li H
    J Investig Med; 2013 Mar; 61(3):604-12. PubMed ID: 23360843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
    Chen H; Cai K
    In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
    PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
    Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
    Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4.
    Xiao Y; Zhang X; Fan S; Cui G; Shen Z
    PLoS One; 2016; 11(12):e0168078. PubMed ID: 27992564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.